Evolutionary conservation of Infection-Induced cell death inhibition among Chlamydiales

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Karunakaran, Karthika ^a   Mehlitz, Adrian ^a   Rudel, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYTOCHROME C; DEATH RECEPTOR; INHIBITOR OF APOPTOSIS PROTEIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; BIRC3 PROTEIN, HUMAN; CASPASE; INHIBITOR OF APOPTOSIS PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRESS; CELL SURVIVAL; CHLAMYDIACEAE; CHLAMYDIASIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC CONSERVATION; HOST CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOCHONDRION; NONHUMAN; OLIGOMERIZATION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SIMKANIA NEGEVENSIS; ANIMAL; DRUG ANTAGONISM; GENETICS; HELA CELL; METABOLISM; MOLECULAR EVOLUTION; PHYSIOLOGY; SECRETION; UPREGULATION;

CHLAMYDIA; CHLAMYDIALES; SIMKANIA; SIMKANIA NEGEVENSIS;

ANIMALS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL DEATH; CHLAMYDIALES; CYTOCHROMES C; EVOLUTION, MOLECULAR; HELA CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; UP-REGULATION;

EID: 79960666257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022528     Document Type: Article

References (65)

1. Kahane S, Gonen R, Sayada C, Elion J, Friedman MG, (1993) Description and partial characterization of a new Chlamydia-like microorganism. FEMS Microbiol Lett 109: 329-333.
2. Everett KD, Bush RM, Andersen AA, (1999) Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 49 Pt 2: 415-440.
3. Corsaro D, Greub G, (2006) Pathogenic potential of novel Chlamydiae and diagnostic approaches to infections due to these obligate intracellular bacteria. Clin Microbiol Rev 19: 283-297.
4. Kahane S, Greenberg D, Friedman MG, Haikin H, Dagan R, (1998) High prevalence of "Simkania Z," a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis 177: 1425-1429.
5. Greenberg D, Banerji A, Friedman MG, Chiu CH, Kahane S, (2003) High rate of Simkania negevensis among Canadian inuit infants hospitalized with lower respiratory tract infections. Scand J Infect Dis 35: 506-508.
6. Greub G, (2009) Parachlamydia acanthamoebae, an emerging agent of pneumonia. Clin Microbiol Infect 15: 18-28.
7. Lamoth F, Greub G, (2010) Fastidious intracellular bacteria as causal agents of community-acquired pneumonia. Expert Rev Anti Infect Ther 8: 775-790.
8. Lieberman D, Schlaeffer F, Porath A, (1997) Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing 26: 69-75.
9. Heiskanen-Kosma T, Paldanius M, Korppi M, (2008) Simkania negevensis may be a true cause of community acquired pneumonia in children. Scand J Infect Dis 40: 127-130.
10. Nascimento-Carvalho CM, Cardoso MR, Paldanius M, Barral A, Araujo-Neto CA, et al. (2009) Simkania negevensis infection among Brazilian children hospitalized with community-acquired pneumonia. J Infect 58: 250-253.
11. Lieberman D, Dvoskin B, Lieberman DV, Kahane S, Friedman MG, (2002) Serological evidence of acute infection with the Chlamydia-like microorganism Simkania negevensis (Z) in acute exacerbation of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis 21: 307-309.
12. Husain S, Kahane S, Friedman MG, Paterson DL, Studer S, et al. (2007) Simkania negevensis in bronchoalveolar lavage of lung transplant recipients: a possible association with acute rejection. Transplantation 83: 138-143.
13. Lieberman D, Kahane S, Friedman MG, (1997) Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism "Z". Am J Respir Crit Care Med 156: 578-582.
14. Kahane S, Everett KD, Kimmel N, Friedman MG, (1999) Simkania negevensis strain ZT: growth, antigenic and genome characteristics. Int J Syst Bacteriol 49 Pt 2: 815-820.
15. Zychlinsky A, Sansonetti P, (1997) Apoptosis in bacterial pathogenesis. J ClinInvest 100: 493-496.
16. Bohme L, Rudel T, (2009) Host cell death machinery as a target for bacterial pathogens. Microbes Infect 11: 1063-1070.
17. Muller A, Gunther D, Brinkmann V, Hurwitz R, Meyer TF, et al. (2000) Targeting of the pro-apoptotic VDAC-like porin (PorB) of Neisseria gonorrhoeae to mitochondria of infected cells. EMBO J 19: 5332-5343.
18. Bantel H, Sinha B, Domschke W, Peters G, Schulze-Osthoff K, et al. (2001) alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol 155: 637-648.
19. Zychlinsky A, Prevost MC, Sansonetti PJ, (1992) Shigella flexneri induces apoptosis in infected macrophages. Nature 358: 167-169.
20. Monack DM, Raupach B, Hromockyj AE, Falkow S, (1996) Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proceedings of the National Academy of Sciences 93: 9833-9838.
21. Schoier J, Ollinger K, Kvarnstrom M, Soderlund G, Kihlstrom E, (2001) Chlamydia trachomatis-induced apoptosis occurs in uninfected McCoy cells late in the developmental cycle and is regulated by the intracellular redox state. Microbial pathogenesis 31: 173-184.
22. Greub G, Mege JL, Raoult D, (2003) Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis [corrected]. Infection and immunity 71: 5979-5985.
23. Fan T, Lu H, Hu H, Shi L, McClarty GA, et al. (1998) Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187: 487-496.
24. Clifton DR, Goss RA, Sahni SK, van Antwerp D, Baggs RB, et al. (1998) NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci U S A 95: 4646-4651.
25. Kurokawa M, Kornbluth S, (2009) Caspases and kinases in a death grip. Cell 138: 838-854.
26. Kroemer G, Reed JC, (2000) Mitrochondrial control of cell death. Nature Med 6: 513-519.
27. Youle RJ, Strasser A, (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59.
28. Brenner D, Mak TW, (2009) Mitochondrial cell death effectors. Curr Opin Cell Biol 21: 871-877.
29. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, et al. (2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11: 519-527.
30. Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, et al. (2005) XIAP inhibits caspase-3 and-7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J 24: 645-655.
31. Gyrd-Hansen M, Meier P, (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10: 561-574.
32. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, et al. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms. Science 286: 1358-1362.
33. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
34. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, et al. (1998) Regulation of cell-death protease caspase-9 by phosphorylation. Science 282: 1318-1321.
35. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
36. Downward J, (1999) How BAD phosphorylation is good for survival. Nature Cell Biology 1: E33-E35.
37. Sharma M, Rudel T, (2009) Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS Immunol Med Microbiol 55: 154-161.
38. Fischer SF, Harlander T, Vier J, Hacker G, (2004) Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step. Infection and Immunity 72: 1107-1115.
39. Fischer SF, Schwarz C, Vier J, Hacker G, (2001) Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infection & Immunity 69: 7121-7129.
40. Rajalingam K, Al Younes H, Muller A, Meyer TF, Szczepek AJ, et al. (2001) Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infection & Immunity 69: 7880-7888.
41. Bohme L, Albrecht M, Riede O, Rudel T, (2010) Chlamydia trachomatis-infected host cells resist dsRNA-induced apoptosis. Cell Microbiol 12: 1340-1351.
42. Rajalingam K, Sharma M, Lohmann C, Oswald M, Thieck O, et al. (2008) Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells. PLoS ONE 3: e3102.
43. Rajalingam K, Sharma M, Paland N, Hurwitz R, Thieck O, et al. (2006) IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells. PLoS Pathog 2: e114.
44. Paland N, Rajalingam K, Machuy N, Szczepek A, Wehrl W, et al. (2006) NF-kappaB and inhibitor of apoptosis proteins are required for apoptosis resistance of epithelial cells persistently infected with Chlamydophila pneumoniae. Cellular Microbiology 8: 1643-1655.
45. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, et al. (2004) Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 200: 905-916.
46. Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, et al. (2005) Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun 73: 1861-1864.
47. Verbeke P, Welter-Stahl L, Ying S, Hansen J, Hacker G, et al. (2006) Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathog 2: e45.
48. Yuasa T, Ohno S, Kehrl JH, Kyriakis JM, (1998) Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 273: 22681-22692.
49. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, et al. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331-367.
50. Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, et al. (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311: 847-851.
51. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD, (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
52. Ying S, Seiffert BM, Hacker G, Fischer SF, (2005) Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis. Infect Immun 73: 1399-1403.
53. Vlahos CJ, Matter WF, Hui KY, Brown RF, (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
54. Matsuo J, Hayashi Y, Nakamura S, Sato M, Mizutani Y, et al. (2008) Novel Parachlamydia acanthamoebae quantification method based on coculture with amoebae. Applied and environmental microbiology 74: 6397-6404.
55. Prakash H, Becker D, Bohme L, Albert L, Witzenrath M, et al. (2009) cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection. PLoS One 4: e6519.
56. Vaux DL, Silke J, (2005) IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 6: 287-297.
57. Coombes BK, Mahony JB, (2002) Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol 4: 447-460.
58. Romashkova JA, Makarov SS, (1999) NF-kappa B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90.
59. Plas DR, Thompson CB, (2005) Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24: 7435-7442.
60. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, et al. (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6: 41-51.
61. Gagnon V, St-Germain ME, Parent S, Asselin E, (2003) Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. International journal of oncology 23: 803-810.
62. Peters J, Wilson DP, Myers G, Timms P, Bavoil PM, (2007) Type III secretion a la Chlamydia. Trends in microbiology 15: 241-251.
63. Kahane S, Kimmel N, Friedman MG, (2002) The growth cycle of Simkania negevensis. Microbiology 148: 735-742.
64. Greub G, La Scola B, Raoult D, (2004) Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerging infectious diseases 10: 470-477.
65. Hsu YT, Youle RJ, (1997) Nonionic detergents induce dimerization among members of the Bcl-2 family. The Journal of biological chemistry 272: 13829-13834.